Jadelle

Levonorgestrel, the active ingredient in Jadelle, is a progestin presented as an implant for subcutaneous use. It prevents pregnancy in women of reproductive age by providing long‑acting hormonal contraception. GNH USA supplies Jadelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levonorgestrel is a progestin used in hormonal contraception to prevent pregnancy.

Contraception: provides a long‑acting reversible birth control method for up to five years. Family planning: offers a reliable option for women seeking sustained pregnancy prevention. Prevention of pregnancy: delivers continuous progestogenic activity to inhibit ovulation and fertilisation.

Levonorgestrel implants are generally well tolerated, but some users experience adverse reactions.

Common Side Effects: - Irregular vaginal bleeding or spotting - Amenorrhea (absence of periods) - Headache - Weight gain - Acne or skin changes - Mood swings or irritability

Serious or Rare Side Effects: - Ectopic pregnancy - Severe allergic reaction (anaphylaxis) - Infection at the insertion site - Pelvic inflammatory disease - Deep vein thrombosis or other thromboembolic events

Before implantation, clinicians should evaluate patient suitability and counsel on expected outcomes.

Screen for contraindications: ensure no history of thromboembolic disorders, liver disease, or hormone‑sensitive cancers. Assess menstrual history: discuss potential changes in bleeding patterns. Monitor insertion site: watch for signs of infection or improper placement. Consider drug interactions: review concurrent medications that may affect hormonal efficacy. Provide counseling on side effects: inform patients about common and serious adverse events. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levonorgestrel implants may have altered effectiveness when used with certain medicines.

Major Interactions (Avoid): - Enzyme‑inducing antiepileptics (e.g., carbamazepine, phenytoin): may markedly reduce contraceptive efficacy. - Rifampicin or rifabutin: can lower plasma levonorgestrel levels. - Griseofulvin: may diminish hormonal activity.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline, ampicillin): may slightly decrease effectiveness. - Antiretroviral drugs (e.g., efavirenz): may reduce hormone concentrations. - St. John’s wort (hypericum perforatum): may modestly lower contraceptive reliability.